Current Investments


Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication.

Fusionhttp://www.fusionpharma.comFusion Pharmaceuticals

Fusion Pharmaceuticals is a targeted radioimmunotherapeutics company focused in creating novel alpha emitting therapeutics for cancer.

Functional Neuromodulation Ltd.http://www.fxneuromod.comFunctional Neuromodulation Ltd. logo

Functional Neuromodulation Ltd. is a start-up medical technology company focused on advancing innovative neuromodulation technologies for the treatment of cognitive and memory disorders.

Impopharmahttp://www.impopharma.comImpopharma logo

Impopharma Inc. is a pharmaceutical company focused on the development of nasal and pulmonary products.

Invitae Corporationhttp://invitae.comInvitae Corporation logo

Invitae Corporation is a company focused on commercial applications of next generation sequencing. The company is applying advances in genomics to provide more comprehensive, less costly, higher quality clinical genetic solutions for patient, providers and payer alike.

Profound Medical Inc.http://www.profoundmedical.comProfound Medical Inc. logo

Profound Medical Inc., founded in June 2008, is a privately-held medical device company dedicated to developing a novel treatment for Prostate Cancer; delivering the fastest, least-invasive, and highest Quality-of-Life outcomes for patients of the disease.

Therapeutic Monitoring Systemshttp://www.therapeuticmonitoring.comTherapeutic Monitoring Systems logo

Therapeutic Monitoring Systems is a software development company.  Its CIMVA software platform holds the promise of greatly enhancing patient care while saving the healthcare system significant costs associated with clinical uncertainty.

Tioga Pharmaceuticals, Inc. Pharmaceuticals, Inc. logo

Tioga Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of pruritus.  Tioga's lead compound, asimadoline, is in a Phase 2 study in patients with pruritus due to atopic dermatitis.